We are live on !
Find out more
EP
Elkfork Partners Portfolio holdings
AUM
$4.11B
Turnover
7.52%
1-Year Est. Return
5.26%
This Fund
S&P 500
This Quarter Est. Return
+1.27%
1 Year Est. Return
+5.26%
3 Year Est. Return
+52.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.11B
AUM Growth
+$18.6M
(+0.45%)
Cap. Flow
-$4.43M
Cap. Flow % of AUM
Cap. Flow %
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
26.54%
Holding
1,091
New
44
Increased
380
Reduced
255
Closed
38
Avg Time Held
2.2
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pluralsight, Inc. Class A Common Stock
PS
|
+$14.6M |
| 2 |
Microsoft
MSFT
|
+$13.8M |
| 3 |
Citigroup
C
|
+$11.7M |
| 4 |
Amazon
AMZN
|
+$10.5M |
| 5 |
Splunk Inc
SPLK
|
+$9.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$14.5M |
| 2 |
Wells Fargo
WFC
|
+$12.3M |
| 3 |
Fortinet
FTNT
|
+$12.2M |
| 4 |
Cognizant
CTSH
|
+$11.4M |
| 5 |
MetLife
MET
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.89% |
| 2 | Financials | 15.38% |
| 3 | Consumer Discretionary | 12.11% |
| 4 | Healthcare | 10.73% |
| 5 | Communication Services | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MYOK
1001
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $38K | ﹤0.01% |
728
| – | – |
2018 Q4
3 quarters
|
|
1002
Vermilion Energy
VET
$2.09B
| $37K | ﹤0.01% |
2,268
| – | – |
2016 Q4
11 quarters
|
|
1003
DELISTED
ENVESTNET, INC.
ENV
| $35K | ﹤0.01% |
612
| – | – |
2018 Q4
3 quarters
|
|
|
TWO
1004
DELISTED
Two Harbors Investment
TWO
| $34K | ﹤0.01% |
649
-814
| -56% | -$42.9K |
2019 Q1
2 quarters
|
|
1005
Everpure Inc
P
$42.3B
| $33K | ﹤0.01% |
1,972
-8,772
| -82% | -$138K |
2019 Q1
2 quarters
|
|
1006
Q2 Holdings
QTWO
$4.14B
| $32K | ﹤0.01% |
408
| – | – |
2018 Q4
3 quarters
|
|
1007
DELISTED
Dayforce
DAY
| $32K | ﹤0.01% |
638
-22
| -3% | -$1.15K |
2019 Q1
2 quarters
|
|
1008
Pegasystems
PEGA
$5.55B
| $31K | ﹤0.01% |
924
| – | – |
2019 Q1
2 quarters
|
|
1009
Roku
ROKU
$23B
| $31K | ﹤0.01% |
+308
| New | +$37.7K |
2019 Q3
0 quarters
|
|
1010
Agios Pharmaceuticals
AGIO
$1.82B
| $29K | ﹤0.01% |
902
+616
| +215% | +$25.5K |
2018 Q1
6 quarters
|
|
1011
Angi Inc
ANGI
$243M
| $29K | ﹤0.01% |
411
-234
| -36% | -$24K |
2019 Q2
1 quarter
|
|
|
XLRN
1012
DELISTED
Acceleron Pharma
XLRN
| $29K | ﹤0.01% |
726
-110
| -13% | -$4.77K |
2018 Q1
6 quarters
|
|
|
HT
1013
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $28K | ﹤0.01% |
+1,904
| New | +$29.1K |
2019 Q3
0 quarters
|
|
1014
Halozyme
HALO
$14.9B
| $27K | ﹤0.01% |
+1,760
| New | +$29K |
2019 Q3
0 quarters
|
|
1015
Syndax Pharmaceuticals
SNDX
$1.22B
| $27K | ﹤0.01% |
3,584
| – | – |
2018 Q4
3 quarters
|
|
1016
Armstrong World Industries
AWI
$6.96B
| $26K | ﹤0.01% |
272
-17,034
| -98% | -$1.64M |
2018 Q1
6 quarters
|
|
|
IPHI
1017
DELISTED
INPHI CORPORATION
IPHI
| $26K | ﹤0.01% |
+418
| New | +$25.5K |
2019 Q3
0 quarters
|
|
1018
MeiraGTx Holdings
MGTX
$911M
| $25K | ﹤0.01% |
+1,562
| New | +$36.4K |
2019 Q3
0 quarters
|
|
1019
aTyr Pharma
ATYR
$12.4M
| $25K | ﹤0.01% |
177
| – | – |
2016 Q4
11 quarters
|
|
1020
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $25K | ﹤0.01% |
204
| – | – |
2018 Q3
4 quarters
|
|
1021
Adaptive Biotechnologies
ADPT
$4.25B
| $24K | ﹤0.01% |
+770
| New | +$31.4K |
2019 Q3
0 quarters
|
|
|
NUAN
1022
DELISTED
Nuance Communications, Inc.
NUAN
| $24K | ﹤0.01% |
1,682
-10,154
| -86% | -$146K |
2018 Q4
3 quarters
|
|
1023
DocuSign
DOCU
$15.4B
| $22K | ﹤0.01% |
352
| – | – |
2018 Q4
3 quarters
|
|
1024
Heron Therapeutics
HRTX
$52.7M
| $22K | ﹤0.01% |
1,204
| – | – |
2019 Q2
1 quarter
|
|
1025
Methanex
MEOH
$5.54B
| $22K | ﹤0.01% |
646
| – | – |
2016 Q4
11 quarters
|
|
Similar funds
GHCM
FCM
NA
MCIM
TAM
TAM
RCM
Elkfork Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Elkfork Partners held 1,091 positions worth $4.11B, up 0.45% from $4.09B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Elkfork Partners's Q3 2019 filing shows 44 new, 380 increased, 255 reduced and 38 closed positions. Its largest new stake was TSMC: 39,844 shares worth $1.85M. The largest sale was Centene, an estimated $14.5M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Elkfork Partners's largest Q3 2019 buy was TSMC: 39,844 shares worth $1.85M.
- Elkfork Partners added most to Pluralsight, Inc. Class A Common Stock in Q3 2019, an estimated $14.6M increase.
- Elkfork Partners's biggest Q3 2019 reduction was Centene, cutting an estimated $14.5M.
- Elkfork Partners fully exited Service Properties Trust in Q3 2019, selling an estimated $8.05M.
- Elkfork Partners's ten largest holdings make up 27% of its $4.11B portfolio in Q3 2019.
- Elkfork Partners opened 44 new positions and closed 38 in Q3 2019.
- Elkfork Partners's portfolio value rose 0.45% quarter-over-quarter to $4.11B.
Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.